CORT125281 Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD)
Status:
Completed
Trial end date:
2018-06-25
Target enrollment:
Participant gender:
Summary
This initial Phase I study will evaluate the dose-related safety and tolerability
pharmacokinetics (PK) of CORT125281, and CORT125324 (active metabolite), and pharmacodynamics
(PD) after single and multiple ascending oral doses of CORT125281 in healthy subjects.